Stock Analysis

Craneware First Half 2025 Earnings: EPS: US$0.21 (vs US$0.12 in 1H 2024)

AIM:CRW
Source: Shutterstock
Advertisement

Craneware (LON:CRW) First Half 2025 Results

Key Financial Results

  • Revenue: US$100.0m (up 9.7% from 1H 2024).
  • Net income: US$7.24m (up 78% from 1H 2024).
  • Profit margin: 7.2% (up from 4.5% in 1H 2024). The increase in margin was driven by higher revenue.
  • EPS: US$0.21 (up from US$0.12 in 1H 2024).
earnings-and-revenue-growth
AIM:CRW Earnings and Revenue Growth March 12th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Craneware Earnings Insights

Looking ahead, revenue is forecast to grow 8.1% p.a. on average during the next 3 years, compared to a 8.7% growth forecast for the Healthcare Services industry in the United Kingdom.

Performance of the British Healthcare Services industry.

The company's shares are down 3.3% from a week ago.

Balance Sheet Analysis

While earnings are important, another area to consider is the balance sheet. We have a graphic representation of Craneware's balance sheet and an in-depth analysis of the company's financial position.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About AIM:CRW

Craneware

Develops, licenses, and supports computer software for the healthcare industry in the United States.

Reasonable growth potential with proven track record and pays a dividend.

Advertisement